scholarly journals Oxcarbazepine and spasticity: further observations

1988 ◽  
Vol 46 (4) ◽  
pp. 382-384 ◽  
Author(s):  
Paulo Rogério M. Bittencourt

The previously described anti-spastic effect of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine was found accidentally in 2 patients undergoing a double-blind comparative study lor evaluation of antiepileptic effect. In this study oxcarbazepine was given orally in doses of 300-2700 mg daily to one patient with transverse myelitis and to two patients with multiple sclerosis, all of whom had clinically disabling spasticity in the form of difficulty in walking, lower limb rigidity, spastic contractions of the lower limbs and ankle clonus. Anti-spastic effect was observed at doses between 600-1200 mg daily and consisted in a substantial decrease in the above symptoms of spasticity. The anti-spastic effect appears at a dose immediately below that which produces nausea, dizziness and somnolence.

Author(s):  
Raja Avinash ◽  
Praveen Kumar Singh

Background: Pain relief is of paramount importance in patients undergoing surgery during perioperative and post-operative period. After effective pain relief a smoother post-operative period and early discharge from the hospital is anticipated. Intrathecal and epidural narcotics have been widely used to relieve pain and provide post-operative analgesia. Here three drugs tramadol, fentanyl, and clonidine used as adjuvant with bupivacaine in intrathecal injection for post-operative pain relief and comparative study had been done.Methods: After the study protocol was approved by the Ethical clearance committee of the DMCH, Laheriasarai, Bihar. Study design was prospective, randomized and double-blind techniques. A group of 80 patients undergoing lower abdominal and lower limb surgery were included in the study. Every patient was fully explained about the anaesthesia and surgical procedure before inclusion in the study. The patients were in the (25-65) years age group and belonged to the American Society of Anaesthesiologist (ASA) physical status class I-II and scheduled for lower abdominal and lower limbs surgery were randomly allocated to four groups with equal number: group B [Bupivacaine (35)% 3 cc + 0.4 cc normal saline], group BT [Bupivacaine (5)% 3 cc + 25 mg tramadol], BC [Bupivacaine (0.5)% 3 c.c + 30 μg clonidine], BF [Bupivacaine (0.5)% 3 c.c + 20 μg fentanyl]. All additive drugs used intrathecally were preservative free. All intrathecal punctures were performed in the lateral (Right or Left) position with a (25G) Quinke needle, using the midline approach at the L3-L4 intervertebral space.Results: The study revealed that administration of additives in group BC and group BF did prolong analgesia. In group B, duration of analgesia and mean duration of rescue analgesic requirement was (3.57±0.45) hrs. For group BC it was (9.47±0.85) hrs, for group BF (7.6±1.14) hrs, for group BT (3.72±0.42) hrs.Conclusions:Addition of adjuvants (Fentanyl, Clonidine) to intrathecal bupivacaine for perioperative pain relief does prolong postoperative analgesia and improves the intraoperative quality of analgesia than bupivacaine alone.Background: Pain relief is of paramount importance in patients undergoing surgery during perioperative and post-operative period. After effective pain relief a smoother post-operative period and early discharge from the hospital is anticipated. Intrathecal and epidural narcotics have been widely used to relieve pain and provide post-operative analgesia. Here three drugs tramadol, fentanyl, and clonidine used as adjuvant with bupivacaine in intrathecal injection for post-operative pain relief and comparative study had been done.Methods: After the study protocol was approved by the Ethical clearance committee of the DMCH, Laheriasarai, Bihar. Study design was prospective, randomized and double-blind techniques. A group of 80 patients undergoing lower abdominal and lower limb surgery were included in the study. Every patient was fully explained about the anaesthesia and surgical procedure before inclusion in the study. The patients were in the (25-65) years age group and belonged to the American Society of Anaesthesiologist (ASA) physical status class I-II and scheduled for lower abdominal and lower limbs surgery were randomly allocated to four groups with equal number: group B [Bupivacaine (35)% 3 cc + 0.4 cc normal saline], group BT [Bupivacaine (5)% 3 cc + 25 mg tramadol], BC [Bupivacaine (0.5)% 3 c.c + 30 μg clonidine], BF [Bupivacaine (0.5)% 3 c.c + 20 μg fentanyl]. All additive drugs used intrathecally were preservative free. All intrathecal punctures were performed in the lateral (Right or Left) position with a (25G) Quinke needle, using the midline approach at the L3-L4 intervertebral space.Results: The study revealed that administration of additives in group BC and group BF did prolong analgesia. In group B, duration of analgesia and mean duration of rescue analgesic requirement was (3.57±0.45) hrs. For group BC it was (9.47±0.85) hrs, for group BF (7.6±1.14) hrs, for group BT (3.72±0.42) hrs.Conclusions: Addition of adjuvants (Fentanyl, Clonidine) to intrathecal bupivacaine for perioperative pain relief does prolong postoperative analgesia and improves the intraoperative quality of analgesia than bupivacaine alone.


Author(s):  
Priscila De Souza Valente ◽  
Priscilane De Souza Valente ◽  
Augusta Da Silva ◽  
Guilherme Peixoto Tinoco Arêas ◽  
Renato Campos Freire Júnior ◽  
...  

Introduction: The technique of neural mobilization promotes ease in carrying out the movement and they  elasticity of the nervous system, creating and perfecting  straining their normal functions, with resulting increase in range of motion . Objective: The aim of this study was to evaluate the effects of neural mobilization of the brachial plexus on the gain range of motion in the lower limbs in asymptomatic individuals. Method: The evaluation was conducted in three steps , immediate post-neural pre-mobilization and post - late , by testing the 3rd finger  to the ground test and fleximetry. The technique of brachial plexus neural mobilization was applied for ten days, with three weekly sessions to complete ten days (four weeks), performed on alternate days, with a minimum interval of 24 hours between sessions. The sample consisted of 17 sedentary college students, between 18 and30 years, . All statistical analysis was performed with (p<0.05). Results: In assessing the hamstrings and quadriceps with fleximeter there was not a statistically significant gain range of motion after neural mobilization , however, there was a significant increase in overall flexibility evaluated with the test of the 3rd finger soil to reach the left finger. Conclusion: In this study, neural mobilization brachial plexus got no efficacy to gain range of motion of the lower limbs in asymptomatic individuals. However, the overall results showed earned flexibility to reach the left finger.


2020 ◽  
pp. 1-2
Author(s):  
Vasireddy Teja ◽  
Y.V.S. Prabhakar ◽  
Bollu Prasanthi

INTRODUCTION Transverse myelitis (TM) is a focal inflammatory disorder of the spinal cord, often associated with infectious disease, which can lead to permanent paraplegia or quadriplegia. CASE REPORT: A 56-year-female ,presentedwithb/l lower limb weakness since 2 days,b/l lower limb loss of sensations since two days,inability to walk since one day,and urinary retention requiring catherisation and fecal incontinence since one day. By history there was also , intermittent fever and night sweats. There was past history of respiratory tract infection two weeks back which partially subsided with antibiotics.Patient is known hypertensive and hypotyroid. Vitals:-normal General physical examination showed moderate general condition, and presence of crackles in both lungs. Neurological examination :- arreflecticlowerlimbs,paraplegia inboth lower limbs (strength 0/5 according to the Medical Research Council grade), and a positive Babinski sign,loss of all sensations completely below umbilicus. CONCLUSION- Tuberculous transversal myelitis is rare but should be consid- ered in the differential diagnosis of non-compressive myelopa- thies, in high burden TB countries or in the presence of clinical symptoms suggestiveofTB


1995 ◽  
Vol 2 (8) ◽  
pp. 683-686 ◽  
Author(s):  
Philippe Bertrand ◽  
Anne Delhommais ◽  
Daniel Alison ◽  
Philippe Rouleau

Author(s):  
Shahram Oveisgharan ◽  
Zahra Karimi ◽  
Siamak Abdi ◽  
Hajir Sikaroodi

Background: Transcranial direct current stimulation (tDCS) of the primary motor cortex of the lower limb has been exploited in the treatment of patients with stroke and spastic lower limb paresis. We examined this stimulation efficacy in the treatment of multiple sclerosis (MS)-related walking disability. Methods: In a single-center randomized doubleblind clinical trial study, 13 patients with MS and walking disability and Expanded Disability Status Scale (EDSS) score of 3 to 6 were randomized to the real and sham stimulation groups. In the real tDCS stimulation, 7 patients received anodal 2.5 mA stimulation at 1 cm anterior to the Cz point for 30-minute daily sessions in 7 consecutive days. The other group received sham stimulation with the same protocol. The primary outcome of the trial was change in the Timed 25-Foot Walk (T25-FW) from before to after the stimulation. We also assessed the Multiple Sclerosis Walking Scale-12 (MSWS-12). We employed linear mixed effects model to examine the efficacy of tDCS stimulation on changing the outcomes. Results: On average, patients who received real tDCS stimulation walked faster after 7 sessions of stimulation [Estimate = -2.7, standard error (SE) = 1.3, P = 0.049], while walking speed of sham stimulation recipients did not change. For every session of stimulation, recipients of real tDCS stimulation spent 2.7 seconds less for walking the 25 feet. Real tDCS stimulation was not effective in improving MSWS-12 scores. Conclusion: tDCS stimulation of the lower limb motor cortex speeded up patients with MS in walking, but without improvement in patients’ mobility in daily activities.  


2020 ◽  
Vol 28 (4) ◽  
pp. 356-360
Author(s):  
Afia Arshed Dodhy

Objective: The purpose of the study was to compare the effectiveness of dexmedetomidine and ondansetron to prevent shivering in patients  undergoing lower limb surgeries after spinal anaesthesia . Methods: This  randomised  double-blind and  placebo-control study trial was held in orthopaedic operation theatre of Lahore General Hospital, Lahore from February 2020 to June 2020. Total of 120  adult patients  who underwent elective orthopaedic surgery of lower limbs after spinal anaesthesia  were divided  into 3 batches. In Batch S, saline was given as  placebo, in Batch O ondansetron and in Batch D dexmedetomidine was administered and shivering score were assessed for 45 min. A shivering score of   ? 3 was considered as primary outcome. Results: There is  statistically considerable difference, in the incidence of significant shivering (grade 3 & 4), among batches, as established by one way ANOVA. The significance value is 0.004 (i.e. p=0.004). There was no significant difference statistically between batch D and batch O (p=0.878) Conclusion: The incidence of shivering in batch S  was considerably higher than  that of both Batch O and  batch D while no significant relationship could be proved in between batch D and batch O Key words: Dexmedetomedine, Ondansetron, Shivering, Spinal Anaesthesia


Sign in / Sign up

Export Citation Format

Share Document